Mirae Asset Global Investments Co. Ltd. Has $71,000 Holdings in Indivior PLC $INDV

Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Indivior PLC (NASDAQ:INDV) by 16.0% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 4,820 shares of the company’s stock after buying an additional 666 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Indivior were worth $71,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Cannon Global Investment Management LLC acquired a new stake in Indivior during the 1st quarter worth about $95,000. Schaper Benz & Wise Investment Counsel Inc. WI acquired a new stake in Indivior during the 1st quarter worth about $95,000. CTC Alternative Strategies Ltd. acquired a new stake in Indivior during the 1st quarter worth about $96,000. Y Intercept Hong Kong Ltd acquired a new stake in Indivior during the 1st quarter worth about $207,000. Finally, New York State Common Retirement Fund acquired a new position in shares of Indivior in the 1st quarter valued at about $295,000. Institutional investors and hedge funds own 60.33% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on INDV. Weiss Ratings reiterated a “hold (c-)” rating on shares of Indivior in a report on Wednesday, October 8th. HC Wainwright began coverage on Indivior in a report on Wednesday, August 6th. They issued a “buy” rating and a $27.00 target price on the stock. Jefferies Financial Group began coverage on Indivior in a report on Tuesday, July 22nd. They issued a “buy” rating and a $20.00 target price on the stock. Wall Street Zen upgraded Indivior from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 21st. Finally, Craig Hallum upped their target price on Indivior from $27.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $22.00.

Indivior Stock Performance

NASDAQ:INDV opened at $23.78 on Monday. The stock’s 50 day moving average price is $23.51 and its 200 day moving average price is $16.52. Indivior PLC has a 52 week low of $7.33 and a 52 week high of $25.10.

Indivior (NASDAQ:INDV) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.51 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.25. Indivior had a negative return on equity of 86.28% and a net margin of 6.65%.The firm had revenue of $302.00 million for the quarter, compared to the consensus estimate of $239.43 million. Indivior has set its FY 2025 guidance at EPS. On average, equities research analysts predict that Indivior PLC will post 1.22 earnings per share for the current year.

Indivior Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.